Clinical Trial Update: Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ferrous acetyl-aspartate-casein formulation to ferrous sulfate for iron deficiency anemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferrous acetyl-aspartate-casein formulation (ferrous acetyl-aspartate-casein formulation)
• Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | Conditions: Iron Deficiency Anemia | Phase 4 | Status: COMPLETED